Copyright
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Nov 7, 2023; 29(41): 5668-5682
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Published online Nov 7, 2023. doi: 10.3748/wjg.v29.i41.5668
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study
Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Rossella D’Onofrio, Simone Mammone, Giusi Arboretto, Salvatore Auletta, Giuseppe Imperio, Andrea Ventura, Mario Romeo, Alessandro Federico, Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania Luigi Vanvitelli, Naples 80138, Italy
Tommaso Durante, Mental Health Department, S. Pio Hospital, Benevento 82100, Italy
Author contributions: Gravina AG, Pellegrino R, and Federico A designed the study; all authors participated in the acquisition and interpretation of the data and drafted the initial manuscript; Pellegrino R performed the analysis; all the authors revised the article critically for important intellectual content.
Institutional review board statement: The study was conducted in compliance with the Declaration of Helsinki and received approval from the Ethics Committee of the University of Campania Luigi Vanvitelli (protocol number 7892, 15 March 2023).
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: There are no conflicts of interest to report.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Raffaele Pellegrino, MD, Department of Precision Medicine, Hepatogastroenterology Unit, University of Campania Luigi Vanvitelli, Via L. de Crecchio, Naples 80138, Italy. raffaele.pellegrino@unicampania.it
Received: August 16, 2023
Peer-review started: August 16, 2023
First decision: October 8, 2023
Revised: October 9, 2023
Accepted: October 23, 2023
Article in press: October 23, 2023
Published online: November 7, 2023
Peer-review started: August 16, 2023
First decision: October 8, 2023
Revised: October 9, 2023
Accepted: October 23, 2023
Article in press: October 23, 2023
Published online: November 7, 2023
Core Tip
Core Tip: The place regular physical activity (PA) should occupy in managing patients with inflammatory bowel diseases (IBD) is unclear. IBD patients were approached to receive an anonymous questionnaire to assess PA levels using the International Physical Activity Questionnaire (IPAQ), assess disease activity as patient-reported outcomes 2, and assess habits, beliefs and barriers in conducting regular PA. A large proportion of included IBD patients were classified as inactive. Patients on biologics therapy showed better IPAQ scores in moderate activities. Inactive patients report some barriers. PA should be an element of discussion in IBD gastroenterology visits.